Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Shranjeno v:

Bibliografske podrobnosti
izdano v:	The New England Journal of Medicine vol. 384, no. 17 (Apr 29, 2021), p. 1589
Glavni avtor:	Pergola, Pablo E
Drugi avtorji:	Farag Youssef MK, Agarwal Rajiv, Arnold, Susan, Bako Gabriel, Block, Geoffrey A, Burke, Steven, Castillo, Fausto P, Jardine, Alan G, Khawaja Zeeshan, Koury, Mark J, Lewis, Eldrin F, Lin, Tim, Luo Wenli, Maroni, Bradley J, Matsushita Kunihiro, McCullough, Peter A, Parfrey, Patrick S, Roy-Chaudhury, Prabir, Sarnak, Mark J, Sharma, Amit, Spinowitz Bruce, Tseng, Carol, Tumlin, James, Vargo, Dennis L, Walters, Kimberly A, Winkelmayer, Wolfgang C, Wittes Janet, Eckardt Kai-Uwe
Izdano:	Massachusetts Medical Society
Teme:	Akebia Therapeutics Inc United States > US Hemodialysis Clinical trials Hypoxia-inducible factors Hemoglobin Cerebral infarction Collaboration Kidney diseases Heart failure Hypoxia Myocardial infarction Confidence intervals Erythropoietin Thromboembolism Drug dosages Erythropoiesis Patients Hydroxylase Anemia Heart attacks Prolyl hydroxylase Design Safety Congestive heart failure Dialysis
Online dostop:	Citation/Abstract Full Text Full Text - PDF
Oznake:	Označite Brez oznak, prvi označite!

Komentirajte kot prvi!